Ann: Major Biopharmaceutical Signs to Patient Engagement Program-MDR.AX, page-35

  1. 4,217 Posts.
    lightbulb Created with Sketch. 238
    Looking at this again - Investor Presentation.

    MDR1.PNG

    And then using the CEO's estimates from yesterday's The Australian article.

    Mr Read said MedAdvisor expected to be in more than 50 per cent of pharmacies in Australia by mid-December and was looking at opportunities to expand internationally. “I think we can get to between two and three million people on the app this year, possibly more,” he said.

    This new updated estimate is two to three times beyond previous estimates and a year earlier.

    Only Management know the current stats and it would be a brave or foolish statement to make if the target numbers didn't eventuate.

    Milestone shares will be awarded to MMG based on the GP Link pilot and HMR (Home Medicine Reviews), all of which are revenue streams for MDR.

    Exciting 6 months coming up.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.9¢
Change
0.001(1.28%)
Mkt cap ! $49.35M
Open High Low Value Volume
7.7¢ 7.9¢ 7.6¢ $102.9K 1.330M

Buyers (Bids)

No. Vol. Price($)
1 200000 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 27812 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.